Anebulo Pharmaceuticals Inc
Industry: Medicinal and Botanical Manufacturing
ANEB Income Statement
|Cost of sales||0||0|
|Gross operating profit||0||0|
|Selling Gen & administrative expense||23351||1 M|
|Research & development expense||150000||2 M|
|Operating income||-173351||-4 M|
|Other income net||0||-27 M|
|Pre-tax Income (EBT)||-174637||-30 M|
|Net income from total operations||-174637||-30 M|
|Total net income||-174637||-30 M|
|Net income available for common||-174637||-30 M|
|Operating income before depreciation (EBITDA)||-173351||-30 M|
|Total Income available for floaterest expense (EBIT)||0||0|
|Basic EPS total||-0.01||-2.83|
|Diluted EPS total||-0.01||-2.83|
Rush Enterprises Inc. Class B Common Stock
Booz Allen Hamilton Holding Corporation
BWX Technologies Inc.
Ritchie Bros. Auctioneers Incorporated
Ituran Location and Control Ltd.
General Mills Inc.
ConAgra Brands Inc.
Agree Realty Corporation
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to firstname.lastname@example.org to avail the extention
From all of us at MarketXLS, thank you!